Similar articles

• DEPDC1 promotes cell proliferation and suppresses sensitivity to chemotherapy in human hepatocellular carcinoma.

  Zhou C, Wang P, Tu M, Huang Y, Xiong F, Wu Y. Zhou C, et al. Biosci Rep. 2019 Jul 10;39(7):BSR20190946. doi: 10.1042/BSR20190946. Print 2019 Jul 31. Biosci Rep. 2019. Retraction in: Biosci Rep. 2024 Jul 31;44(7):BSR-2019-0946_RET. doi: 10.1042/BSR-2019-0946_RET. PMID: 31189746 Free PMC article. Retracted.
• DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.

  Guo W, Li H, Liu H, Ma X, Yang S, Wang Z. Guo W, et al. Oncol Rep. 2019 Sep;42(3):1075-1089. doi: 10.3892/or.2019.7221. Epub 2019 Jul 5. Oncol Rep. 2019. PMID: 31322256 Free PMC article.
• DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.

  Qu D, Cui F, Lu D, Yang Y, Xu Y. Qu D, et al. Cancer Sci. 2019 Jan;110(1):157-165. doi: 10.1111/cas.13867. Epub 2018 Dec 13. Cancer Sci. 2019. PMID: 30417471 Free PMC article.
• Glycolysis-Related Gene Analyses Indicate That DEPDC1 Promotes the Malignant Progression of Oral Squamous Cell Carcinoma via the WNT/β-Catenin Signaling Pathway.

  Huang G, Chen S, Washio J, Paka Lubamba G, Takahashi N, Li C. Huang G, et al. Int J Mol Sci. 2023 Jan 19;24(3):1992. doi: 10.3390/ijms24031992. Int J Mol Sci. 2023. PMID: 36768316 Free PMC article.
• Artemisia argyi Essential Oil Inhibits Hepatocellular Carcinoma Metastasis via Suppression of DEPDC1 Dependent Wnt/β-Catenin Signaling Pathway.

  Li Y, Tian Y, Zhong W, Wang N, Wang Y, Zhang Y, Zhang Z, Li J, Ma F, Zhao Z, Peng Y. Li Y, et al. Front Cell Dev Biol. 2021 Jun 29;9:664791. doi: 10.3389/fcell.2021.664791. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34268303 Free PMC article.